Picture of BBS-Bioactive Bone Substitutes Oyj logo

BONEH — BBS-Bioactive Bone Substitutes Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: BBS-Bioactive Bone Substitutes FY Net Profit At EUR 379,000

March 22 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
 BONEH.HE :
    * REG-FINANCIAL STATEMENT BULLETIN
    * OUTLOOK 2019: BBS WILL DRIVE FORWARD CE MARKING PROCESS OF
FIRST
PRODUCT AND LAUNCH SALES AND MARKETING PREPARATIONS.
    * FOR YEAR 2019, SUBSTANTIAL NET SALES ARE NOT EXPECTED TO
BE
GENERATED.
    * FY NET PROFIT EUR 379,000 VERSUS LOSS EUR 4.5 MILLION YEAR
AGO

Source text for Eikon:  ID:nGNE1DGHKy 
Further company coverage:  BONEH.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))

Recent news on BBS-Bioactive Bone Substitutes Oyj

See all news